Review reports improved transparency in antidepressant drug trials
Racial inequity in follow-up appointment attendance after hospitalization disappears as telemedicine adopted
19 January 2022Artificial intelligence may reduce frequency of adverse drug events
19 January 2022Review reports improved transparency in antidepressant drug trials
New research suggests manufacturers of newly developed antidepressant drugs have become more forthcoming about clinical trials that don’t pan out.
